Cart
sales@molnova.com
Home - Products - GPCR/G Protein - SGLT - Sergliflozin A

Sergliflozin A

CAS No. 360775-96-8

Sergliflozin A( —— )

Catalog No. M36251 CAS No. 360775-96-8

Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 170 Get Quote
5MG 247 Get Quote
10MG 371 Get Quote
25MG 601 Get Quote
50MG 854 Get Quote
100MG 1134 Get Quote
500MG 2277 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Sergliflozin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
  • Description
    Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    SGLT
  • Recptor
    SGLT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    360775-96-8
  • Formula Weight
    376.4
  • Molecular Formula
    C20H24O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C1=C(CC2=CC=C(OC)C=C2)C=CC=C1)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • SHR3824

    SHR3824 is a potent, selective SGLT2 inhibitor with IC50 of 2.38 nM.

  • KGA-2727

    KGA-2727 is a potent and selective SGLT1 inhibitor, with Kis of 97.4 nM and 43.5 nM for human and rat SGLT1, respectively.?The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat).?KGA-2727 for the treatment of diabete.KGA-2727, which has a pyrazole-O-glucoside structure, as the first selective SGLT1 inhibitor.?

  • Tofogliflozin

    Tofogliflozin (CSG-452) is a potent, highly selective SGLT2 inhibitor with Ki of 2.9, 14.9, and 6.4 nM against human, rat, and mouse SGLT2, respectively.

Sign In Join Free